Table 1.
Demographics and baseline characteristics (ITT population)
| Characteristic | Topical finasteride (N = 105) | Placebo (N = 97) | Oral finasteride (N = 48) |
|---|---|---|---|
| Age (years), mean (SD) | 32.5 (5.4) | 31.8 (4.9) | 32.3 (5.5) |
| Weight (kg), mean (SD) | 83.6 (17.5) | 84.3 (14.6) | 83.3 (12.4) |
| Caucasian, n (%) | 103 (98.1) | 96 (99.0) | 46 (95.8) |
| Male pattern baldness†, n (%) | |||
| Type III vertex | 50 (47.6) | 45 (46.4) | 26 (54.2) |
| Type IV | 27 (25.7) | 31 (32.0) | 14 (29.2) |
| Type V | 28 (26.7) | 20 (20.6) | 8 (16.7) |
| Other | 0 (0.0) | 1 (1.0) | 0 (0.0) |
ITT, intention to treat; SD, standard deviation.
†
According to the Norwood/Hamilton Scale.